This suggests that the enhancement of MYC-driven metabolic and epigenetic reprogramming may be a general mechanism that underlies the influence of dietary fat intake on prostate cancer progression although this hypothesis remains to be tested across prostate cancer molecular subtypes. Here, MYC is linked to prostate cancer.